About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | PSA Glycomics Assay for Early Detection of Prostate Cancer

PSA Glycomics Assay for Early Detection of Prostate Cancer

NCT04393376·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

J R Oddens, MD, PhD
CONTACT
+31(0)20-5668637 [email protected]

Lead

Prof.dr. H.P. Beerlage

With

Amsterdam UMC, location VUmc
The Netherlands Cancer Institute
Radboud University Medical Center
Leiden University Medical Center

Age

18–any

Sex

MALE

Healthy volunteers

Accepted

You may be eligible if

Patients with elevated PSA (\>3 ng/mL)
Signed informed consent

You may not be if

Patients that have a cystitis (bladder infection)
Patients under chemotherapy
Patients using 5-alpha reductase inhibitors
History or presence of cancers, or non-prostate urological disorders.

The record

StatusUnknown

PhaseNo phase

Taking part150

StartedAug 2020

UpdatedSep 26, 2023

Conditions

Prostate Cancer PSA

Where3

Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands
Amsterdam UMC, location VUmc
Amsterdam, Netherlands
Leiden University Medical Centre
Leiden, Netherlands